The purpose of this study was to determine the susceptibility of various strains of Mycoplasma bovis, Mycoplasma dispar, and Ureaplasma diversum, which are prevalent causes of pneumonia in calves, to 16 antimicrobial agents in vitro. The MICs of the antimicrobial agents were determined by a serial broth dilution method for 16 field strains and the type strain of M. bovis, for 19 field strains and the type strain of M. dispar, and for 17 field strains of U. diversum. Final MICs for M. bovis and M. dispar were read after 7 days and final MICs for U. diversum after 1 to 2 days. All strains tested were susceptible to tylosin, kitasamycin, and tiamulin but were resistant to nifuroquine and streptomycin. Most strains of U. diversum were intermediately susceptible to oxytetracycline but fuly susceptible to chlortetracycline; most strains of M. bovis and M. dispar, however, were resistant to both agents. Strains of M. dispar and U. diversum were susceptible to doxycycline and minocycline, but strains of M. bovis were only intermediately susceptible. Susceptibility or resistance to chloramphenicol, spiramycin, spectinomycin, lincomycin, or enrofloxacin depended on the species but was not equal for the three species. The type strains of M. bovis and M. dispar were more susceptible to various antimicrobial agents, including tetracyclines, than the field strains. This finding might indicate that M. bovis and M. dispar strains are becoming resistant to these agents. Antimicrobial agents that are effective in vitro against all three mycoplasma species can be considered for treating mycoplasma infections in pneumonic calves. Therefore, tylosin, kitasamycin, and tiamulin may be preferred over oxytetracycline and chlortetracycline.
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Several mycoplasma species, of the many that have been isolated from cattle, are pathogenic. Mycoplasma bovis is regarded as the most pathogenic, with the exception of Mycoplasma mycoides subsp. mycoides small-colony biotype, the agent of contagious bovine pleuropneumonia. M. bovis causes mastitis in dairy cattle, respiratory tract infections in calves, and arthritis in all age groups of cattle, and it is prevalent worldwide (5) . In addition, Mycoplasma dispar and Ureaplasma diversum have frequently been isolated from the respiratory tracts of pneumonic calves, and their prevalence is assumed to be worldwide also (16) . Their pathogenic significance in calf respiratory disease has been proven (7) . U. diversum can also be isolated from the genital tracts of cows and bulls. M. bovis, M. dispar, and U. diversum are prevalent in the Netherlands (23, 25) .
Because bacteria and mycoplasmas are involved in calf pneumonia, calves are often treated with antimicrobial agents. The massive and timely use of macrolide antibiotics, singly or in combination with other drugs, contributed to the recovery of more than 90% of calves affected by pneumonia (12) . Although antimicrobial agents cause calves to recover from the clinical signs of respiratory disease (12), they do not eliminate mycoplasmas from the herd. Although the susceptibility of M. bovis and U. diversum to antimicrobial agents has been studied in vitro (4, 8-11, 13, 14, 20, 22, 28) , little is known about the susceptibility of M. dispar (9, 11) .
In the present study, we examined the susceptibility of numerous strains of these three bovine pathogens to 16 antimicrobial agents by using a serial broth dilution method. (23) . Strains of M. bovis were cultured in modified Edward media containing 0.4% tetrazolium chloride, strains of M. dispar were cultured in Friis NHS20 broth, and strains of U. diversum were cultured in Friis NHU pH 6.0 broth (23) .
Sixteen field strains of M. bovis were isolated from the lungs of pneumonic calves (B16, Fl, Q19, AN13b, AZ25, BD25, BG32, BY47b, DY20b, EA17, and EB14), from mastitic milk (AX20 and DL19), or from synovia collected from arthritic joints (DR40, EO11, and EU46). The strains were isolated from cattle from 14 farms. Nineteen field strains of M. dispar (E6, Q26, V24, Y15, AA9, AF7, AF18d, ASl5d, AS19, AZ11, BA20, BD5, BD8, BI35, BM10, BS18, BX43, BY47d, and DT10) were isolated from the lungs of pneumonic calves from 16 farms. Seventeen field strains of U. diversum were isolated from the lungs (B20, E5, G10, Y9, Y22, V25, AA9, AB13, AF18u, AN13u, ASl5u, AT5, BS19, BY48, and DT8) or noses (B15, Q22) of pneumonic calves from 15 farms. Strains B15, B20, E5, G10, AN13u, AT5, and BY48 had been identified as U. diversum serogroup A; strains Y9 and AA9 had been identified as serogroup B. The other Ureaplasma strains had not been serotyped. The farms from which the three mycoplasma species were isolated were located in various parts of the Netherlands.
Primary cultures of M. bovis strains were purified three times by using a Pasteur pipette to suction an agar plug bearing one colony (6) . Cultures of M. dispar and U. diversum cannot be purified in this way because no viable cultures are obtained. Therefore, primary cultures of M. dispar and U. diversum were purified three times by conventional filtration cloning techniques, by using a 450-nmpore-size membrane filter (26) . After the first filtration step, the culture was serially diluted 10-fold in eight tubes with culture broth. Immediately thereafter, the contents of each tube was transferred to eight wells (200 ,u per well) of a microtiter plate that was sealed with adhesive tape and incubated at 37°C for 7 (U. diversum) or 14 (M. dispar) days. The contents of the well containing the highest dilution of viable culture was serially diluted 10-fold in four tubes of broth medium. The tube containing the highest viable dilution was used for the second and third filtration steps.
Antimicrobial agents. The following antimicrobial agents were used: oxytetracycline, chloramphenicol, streptomycin, ampicillin, and benzylpenicillin potassium (Gist-Brocades, Delft, the Netherlands); chlortetracycline and minocycline (Cyanamid, Lederle, the Netherlands); doxycycline (Pfizer, Rotterdam, the Netherlands); spiramycin (Rhone-Merieux, Toulouse, France); tylosin (Elanco, Nieuwegein, the Netherlands); kitasamycin (Inffa, Houten, the Netherlands); spectinomycin and lincomycin (Upjohn, Ede, the Netherlands); tiamulin (Coopers, Haarlem, the Netherlands); enrofloxacin (Bayer, Mijdrecht, the Netherlands); and nifuroquine (quinaldofur) (Duphar, Amsterdam, the Netherlands).
Tylosin and tiamulin are used only in veterinary medicine. Tylosin is an antibiotic with a structure similar to that of erythromycin. Tiamulin is a semisynthetic antimicrobial agent that does not belong to a particular group. Kitasamycin is a macrolide antibiotic that is used in veterinary medicine. In Japan it has been used successfully in human medicine (15) . The three agents have a spectrum similar to the spectrum of the macrolides. Nifuroquine is a quinoline derivative that is used in therapy of bovine mastitis.
The antimicrobial agents were diluted in distilled water to prepare stock solutions, except for the four tetracyclines, which were diluted in 10% methanol, and chloramphenicol and spiramycin, which were diluted in 0.5% N,N-dimethylformamide (no. 3034; E. Merck AG, Darmstadt, Germany). Concentrations were calculated as pure substances to prepare stock solutions. The activity of spiramycin was equivalent to 4,468 IU/mg, that is, 1.4 times the activity of the World Health Organization standard. The activity of penicillin was equivalent to 1,592 U/mg. Stock solutions were sterilized by filtration through a 200-nm-pore-size membrane filter and used immediately or stored at 4°C overnight. On the day of inoculation, the required numbers of colorchanging units were prepared from stock cultures with a known number of cells, which had been stored at -70°C. Organisms were counted again to verify the actual numbers of organisms in the system. The microtiter plates were sealed with adhesive tape and incubated aerobically at 37°C in the dark to prevent spontaneous reduction of the tetrazolium chloride. The MIC of the antimicrobial agent was determined as the lowest concentration at which the medium did not change color or produce a film layer. The color changes were read several times for 7 days. Because the film developed more slowly than color change, it was read only at day 7. Initial MICs were recorded as soon as the inoculum controls (without the antimicrobial agent) changed color in comparison with the color of the culture medium controls. This was on day 1 to 2 for U. diversum, day 2 to 3 for M. bovis, and day 2 to 4 for M. dispar. Final MICs for M. bovis and M. dispar were read when color changes or film production had stopped for 1 to 2 days, that is, day 7. Because Ureaplasma species grow rapidly, final MICs for U. diversum were read after only 24 to 48 h. These time points for reading MICs were in agreement with the recommendations of the IRPCM working group, which recommended that MICs for Mycoplasma species be read from 48 h to 7 days and that MICs for Ureaplasma species be read after 24 h (18). All tests were performed in duplicate; when MICs differed by no more than a factor of two, the higher concentration of the two was recorded as the MIC.
Interpretation of MICs. When the MIC of the tetracycline group was <1 ,ug/ml, the strain was considered susceptible; when the MIC was 2 or 4 ,ug/ml, it was considered intermediately susceptible; and when the MIC was 28 ,ug/ml, the strain was considered resistant. These values were c4, 8, and 216 ,ug/ml for chloramphenicol; <4, 8 or 16, and >32 ,ug/ml for streptomycin; <2, >4 to .16, and .32 ,ug/ml for ampicillin; and .0.25, .0.5 to <4, and >8 ,g/ml for penicillin (27) . These MICs were based on guidelines for testing the susceptibility of bacteria that affect humans. These criteria were used because criteria for animals are not generally available. Criteria for the other antimicrobial agents were not available.
RESULTS
MICs of antimicrobial agents were determined for 50% of the strains tested (MIC50) and for 90% of the strains tested (MIC90). dardization of methods difficult (3) . Because no single medium is suitable for in vitro testing of all species, we had to use a different medium for each of the three species. Because broth cultures of mycoplasmas develop only faint turbidity, alternative methods must be used to measure mycoplasmal growth, for example, metabolism of glucose, arginine, or urea. A pH indicator such as phenol red visualizes the pH shift due to biochemical activities of multiplying mycoplasmas. Because M. bovis has none of these biochemical activities, however, various methods have been used for in vitro susceptibility testing, including acid production (because M. bovis may slightly acidify the medium) (8), hydrolysis of Tween 80 (4), an agar diffusion method (9, 28), a nephelometric method, and a test for phosphatase (14) . We used tetrazolium reduction as an indicator for growth, as suggested by the IRPCM working group (18) . Because the formazan that was produced stained only slightly red and this color often disappeared after 1 to 2 days, results were confirmed by observing the film layer that developed slowly and could be read only after 7 days of incubation. Furthermore, the growth rate of the various mycoplasma species differs. For example, U. diversum reaches its stationary growth phase within 24 to 48 h, whereas M. dispar reaches this stage after 4 days. This can cause instability of antimicrobial agents in media. A loss of antimycoplasmal activity of tetracyclines during prolonged incubation, in fact, is a well-known phenomenon (3) . Although this may be the reason for the resistance of the Mycoplasma strains to oxytetracycline and chlortetracycline in this study, strains of other species were found to be susceptible after an incubation period of 7 days in an earlier study that used identical methods (24) .
Although the working group of the IRPCM standardized most procedures for testing the susceptibility of mycoplasmas (18) , the length of incubation time has yet to be standardized. The working group recommended that final MICs should be read when the color has stopped changing after a defined period of incubation. In an earlier study, we concluded that this period should not exceed 2 days (24) . In the present study, however, cultures sometimes continued to change color, depending on species, strain, or antimicro- (10, 13, 20, 22) . The resistance of U. urealyticum to lincomycin was reported in 1968 (19) . We confirmed the resistance of U. diversum to lincomycin.
It has been the experience in chemotherapy for decades that two groups of antimicrobial agents, i.e., tetracyclines and macrolides, are of primary importance in treating animal mycoplasma infections. The older tetracyclines, such as oxytetracycline and chlortetracycline, are cheaper than the newer tetracyclines, such as doxycycline and minocycline. The dosage of the newer tetracyclines, however, can be lower, because they are better absorbed after oral administration (3) .
However, bovine mycoplasma strains are acquiring resistance to tetracyclines (in particular, to oxytetracycline), as demonstrated by our study. This finding is notable because oxytetracycline is frequently used in calf husbandry in the Netherlands. M. bovis and M. dispar were less susceptible to doxycycline and minocycline, however, than U. diversum was.
Mycoplasma strains are known to be susceptible to tiamulin and tylosin, although strains are generally more susceptible to tiamulin than to tylosin. The MICs of these antimicrobial agents were low for all strains studied; for one M. bovis strain, however, the MIC of tylosin was as high as 4 ,ug/ml. The U. diversum strains were generally less susceptible to tylosin than strains of M. bovis or M. dispar. Because in other countries some strains were less susceptible to tiamulin (M. bovis) or tylosin (M. bovis and U. diversum), these strains may also be acquiring resistance to tylosin (14, 20) . Another indication that field strains of M. bovis are developing resistance is that the MICs of various antimicrobial agents for type strain Donetta were lower than those for any field strain. The type strain of M. dispar was more susceptible to the tetracyclines than most field strains; this indicates that M. dispar strains are also acquiring resistance.
Because the three mycoplasma species often occur in pneumonic calves of one herd and even in the respiratory tract of one calf (23) , antimicrobial agents that are effective in vitro against all three species can be considered for use in vivo. Therefore, tylosin, kitasamycin, and tiamulin may be preferred over oxytetracycline and chlortetracycline.
